Leveljump Healthcare Corp.
JMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $18 | $13 | $9 | $7 |
| % Growth | 40.9% | 36.3% | 37.3% | – |
| Cost of Goods Sold | $15 | $10 | $7 | $5 |
| Gross Profit | $3 | $2 | $2 | $1 |
| % Margin | 18% | 18.7% | 20.1% | 20.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $2 | $3 | $3 |
| SG&A Expenses | $3 | $3 | $2 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | -$0 | $1 | $0 |
| Operating Expenses | $3 | $3 | $3 | $4 |
| Operating Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -0.2% | -4.6% | -8.7% | -32.2% |
| Other Income/Exp. Net | -$1 | -$2 | $1 | -$0 |
| Pre-Tax Income | -$1 | -$2 | $0 | -$2 |
| Tax Expense | -$2 | $0 | $0 | $0 |
| Net Income | $1 | -$2 | $0 | -$2 |
| % Margin | 6.5% | -17.5% | 2% | -33.2% |
| EPS | 0.012 | -0.024 | 0.002 | -0.047 |
| % Growth | 150% | -1,143.5% | 104.9% | – |
| EPS Diluted | 0.012 | -0.024 | 0.002 | -0.047 |
| Weighted Avg Shares Out | 96 | 92 | 79 | 48 |
| Weighted Avg Shares Out Dil | 110 | 92 | 79 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | $2 | -$1 | -$1 | -$2 |
| % Margin | 8.7% | -9.5% | -6.2% | -32.1% |